Product Reports Resources Pricing Login Book a demo
COMPANY PROFILE

Tessera Therapeutics

Explore full profile

A new genome engineering technology that writes therapeutic messages into the genome to treat diseases at their source

Cambridge, United StatesFounded 2018Biotech & Life Sciences
Valuation $1–2.5B Last recorded · 2026
Revenue $100–500M Latest reported FY
Headcount 100–500 Current team size
Unlock exact values This page shows ranges. Dealroom has the exact numbers for Tessera Therapeutics and the history behind them.

At a glance

Founded
2018
Headquarters
Cambridge, United States
Sector
Biotech & Life Sciences
Power Law
Unicorn$1–10B valuation tierThoroughbred$100M+ revenue

Knowledge graph

News, research, reports and resources connected to this company by Dealroom

Investors

16 investors on the cap table

From Dealroom's funding and investor records, grouped by the round each investor first entered.

Series B and later16 investors entered at this stage

Talent

Book a demo to see the people
Employees mapped 197 incl. 5 AI specialists
Founders Hidden — book a demo/100 quality score
Key operators 9 quality Hidden — book a demo/100
Potential founders Hidden — book a demo likely future founders
Startup mafia 5 alumni-founded startups
Talent movements Hidden — book a demo in · Hidden — book a demo out past 12 months

Source: Dealroom Talent Intelligence.

Alumni founders

5 startups

Former Tessera Therapeutics employees who went on to found companies, sorted by Dealroom signal score.

Liberate BioEst. 2022
Michael J MitchellUnited States
Signal score89
Generate BiomedicinesEst. 2020
Molly GibsonUnited States
Signal score74
Quotient TherapeuticsEst. 2022
Jacob Rubens.United Kingdom
Signal score73
Montai HealthEst. 2022
Noubar AfeyanUnited States
Signal score68
Via ScientificEst. 2022
MMMelissa J. MooreUnited States
Signal score54
Explore the full alumni networkBook a demo

Global footprint

Workforce and web traffic by country
Workforce by country
2 countries with
team presence
🇺🇸 United States98.9%
🇮🇹 Italy1.1%
2 countries shown
Web traffic by country
7.9K monthly visits
across markets
🇺🇸 United States81%
🇯🇵 Japan8.9%
🇮🇳 India6.3%
🇵🇭 Philippines3.8%
🇬🇧 United Kingdom1.3%
Top 5 markets shown

Patents

Estimated portfolio value
$127k

9 active patent families included in this estimate.

A patent family groups patent filings for the same invention. Source: Dealroom · PatSnap.

Explore the patent portfolioPatent records, technology areas and peer comparisonsBook a demo

Market sentiment

Posts on X, past 7 days

An AI-synthesised read of the highest-engagement posts about Tessera Therapeutics on X, ranked by likes and reposts, corporate channels excluded.

Reading the room on X — pulling top posts and synthesizing themes…

Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour

See Tessera Therapeutics on the full Dealroom platform

Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.

Book a demo Explore company profiles